Details for New Drug Application (NDA): 075689
✉ Email this page to a colleague
The generic ingredient in HALOPERIDOL is haloperidol decanoate. There are twenty drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the haloperidol decanoate profile page.
Summary for 075689
Tradename: | HALOPERIDOL |
Applicant: | Fresenius Kabi Usa |
Ingredient: | haloperidol lactate |
Patents: | 0 |
Suppliers and Packaging for NDA: 075689
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
HALOPERIDOL | haloperidol lactate | INJECTABLE;INJECTION | 075689 | ANDA | HF Acquisition Co LLC, DBA HealthFirst | 51662-1524 | 51662-1524-1 | 1 mL in 1 VIAL (51662-1524-1) |
HALOPERIDOL | haloperidol lactate | INJECTABLE;INJECTION | 075689 | ANDA | Cardinal Health 107, LLC | 55154-9553 | 55154-9553-5 | 5 VIAL in 1 BAG (55154-9553-5) / 1 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 5MG BASE/ML | ||||
Approval Date: | Mar 9, 2001 | TE: | AP | RLD: | No |
Complete Access Available with Subscription